Voloridge Investment Management, LLC Kura Oncology, Inc. Transaction History

Voloridge Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$10.71 - $18.33 $460,208 - $787,640	42,970 Added 40.78%	148,340 $2.72 Million
Q1 2022 May 16, 2022	BUY	$11.78 - $16.98 $1.07 Million - $1.55 Million	91,052 Added 635.93%	105,370 $1.69 Million
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $6,586 - $10,548	539 Added 3.91%	14,318 $200,000
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $12,536 - $17,658	-813 Reduced 5.57%	13,779 $258,000
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $304,243 - $436,008	14,592 New	14,592 $304,000
Q1 2021 May 17, 2021	SELL	$24.75 - $39.14 $1.52 Million - $2.4 Million	-61,236 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$29.0 - $41.62 $1.77 Million - $2.54 Million	-61,052 Reduced 49.92%	61,236 $2 Million
Q3 2020 Nov 16, 2020	BUY	$16.3 - $30.64 $1.99 Million - $3.75 Million	122,288 New	122,288 $3.75 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.